Modulation of Calcium Channels in Human Retinal
The objective of this study was to begin to examine the cellular and biophysical effects on human retinal glial cells of basic fibroblast growth factor (bFGF), which is endogenous to the retina and likely to play a role in retinal pathobiology. Experiments were performed on cultured glial cells derived from the adult postmortem retina. A proliferative response to bFGF established a sensitivity of the retinal glia to this growth factor. The possibility that bFGF alters calcium currents was assessed using the whole-cell recording configuration of the patch-clamp technique to analyze inward currents carried by barium. Two types of voltage-gated calcium channels could be expressed by the glial cells. One, similar to the T-type current described in various kinds of cells, had a low threshold of activation, a transient response, and an insensitivity to the dihydropyridine nifedipine. The other type of inward current, which closely resembles the L-type calcium current found in other cells, had a high threshold, had a long-lasting response, and was inhibited by nifedipine. When continuous whole-cell recordings were made from retinal glial cells, the L-type calcium current increased significantly within 20 min after exposure of the cells to bFGF. The physiological significance of this modulatory effect remains uncertain, though the observation that nifedipine inhibits both the L-type calcium current and the bFGF-induced proliferation is consistent with the hypothesis that dihydropyridine-sensitive channels may play a role in modulating the mitogenic response of retinal glial cells to this growth factor.
Although basic fibroblast growth factor (bFGF) is thought to play a role in the pathobiology of the CNS (Gospodarowicz et al., 1986; Sievers et al., 1987; Finkelstein et al., 1988; Faktorovich et al., 1990; Sivalingam et al., 1990 ) knowledge of its effects on cells of the nervous system is limited. In this article, we begin to examine the effects of bFGF on human retinal glial cells. Retinal glial cells were chosen for study for a number of reasons. One reason is recent evidence indicating that these cells have bFGF receptors (Mascarelli et al., 1990) and thus are likely to be targets for this growth factor, which is endogenous to the retina. A second reason for studying bFGF-glial interactions is that glial cells are important in the pathogenesis of retinal disorders, such as proliferative vitreoretinopathy (a complication of retinal detachment) and proliferative diabetic retinopathy (Van Horn et al., 1975; Hamilton et al., 1982; Hiscott et al., 1984; Nork et al., 1987; Jerdan et al., 1989; Sramek et al., 1989; Guerin et al., 1990) , in which bFGF has been postulated to play a role (Gospodarowicz et al., 1986; Sivalingam et al., 1990) . Another reason for focusing on retinal glial cells is the availability of a cell culture system to study glia from the adult human retina.
This study addressed two main questions. The initial question was whether the retinal glial cells in our culture system are sensitive to bFGF. Our finding that bFGF is a potent mitogen for these cells answered this question affirmatively. A mitogenic response is of interest in retinal, as well as CNS, pathobiology because glial cell proliferation occurs frequently in response to trauma, ischemia, inflammation, and other pathological conditions.
Knowing that retinal glial cells are sensitive to bFGF led to the second question, which concerns the biophysical effects of this growth factor. Are calcium channels modulated by bFGF? Effects on calcium channels are of interest because studies of nonocular cells indicate that exposure to bFGF may be associated with an influx of calcium from the extracellular space (Magnaldo et al., 1986; Pandrella et al., 1989) . This influx of calcium may serve as a signal to help mediate bFGF-induced effects on cell activity. Addressing this question concerning modulation first required determining whether human retinal glial cells express calcium channels. Although at least one type of calcium channel has been identified in glial cells of the salamander retina (Newman, 1985) there are no previous studies of calcium currents in mammalian retinal glial cells. Here, we report that human retinal glial cells in culture can express two types of voltage-gated calcium channels (T-and L-types) and that exposure of these cells to bFGF is associated with an increase in the L-type current.
Whether the modulation by bFGF of the L-type calcium current plays a role in mediating the mitogenic effect of this growth factor remains an unresolved issue. However, a link between the modulatory and mitogenic effects of bFGF is suggested by the dihydropyridine sensitivity of both the L-type current and the proliferative response.
Materials and Methods
Cell cultures. Cultures of retinal glial cells were prepared using a modification of methods developed by others (Hjelmeland et al., 1987) . Postmortem eyes from donors aged 19 to 88 yr were supplied within 24 hr of death by the Florida Lions Eye Bank or the Michigan Eye Bank. Retinas were removed, exposed to a calcium-and magnesium-free phosphate buffer (CMF) supplemented with 0.1% trypsin (3 x crystallized; Worthington), 0.2% hyaluronidase (Sigma), and 4% chicken serum (GIBCO Laboratories) for 45 min at 37°C and then dissociated mechanically in 80% medium A (1:l ratio of Dulbecco's modified Eagle's medium and Ham's F12 medium) and 20% fetal bovine serum. Dissociated cells from one retina were added to three 35 mm Petri dishes, kept in a humidified environment of 97% air and 3% CO, at 37"C, and fed with 80% medium A and 20% fetal bovine serum twice per week. Cultures that reached 80-90% confluency were split to three 35-mm Petri dishes. Cells that had been in culture for three to live passages were used in this study.
The cells were classified as glial by their positive immunocytochemical staining with antibodies to glial fibrillary acidic protein (GFAP). As reported elsewhere Puro et al., 1990) , virtually all of the cells stained positively for GFAP. Ultrastructural studies Puro et al., 1990 ) of these cultured cells demonstrated the presence of IO-nm cytoplasmic filaments, which are characteristic of glial cells. In addition, as published Dreviouslv Puro et al., 1990) , nearl; all of the cells in .tge& cultures stained positively by immunocytochemistry with a monoclonal antibody for Miiller's cells.
Recording conditions. One day prior to recording, cultures were washed twice and kept in medium B (medium A supplemented with 50 &ml transferrin and 30 DM sodium selenite). Approximately l-2 hr prior to recording, medium B was replaced with an appropriate bath solution. Unless stated otherwise, the bath solution contained 125 mM CsCl, 10 mM BaCl,, 10 mM glucose, 5 NM tetrodotoxin (TTX), and 10 mM 'Ba-HEPES (pH, 7.3). The uipette solution consisted of 140 mM CsCl. 1 YM Mgdi,, and i0 mM &-HEPES (pH, 7.3). During experiments, the cultures were examined at 400x magnification with an inverted microscope equipped with phase-contrast optics. Cells selected for wholecell recording had rounded cell bodies with diameters of approximately 50-150 pm. A bath solution supplemented with 1 or 10 PM nifedipine could be miniperfused in the area of a glial cell by applying 0.5 psi of pressure from a pressure ejection system (Medical Systems) to the back end ofa pipette with a tip size ofapproximately 5 pm that was positioned about 100 lrn from the cell being recorded. In experiments examining changes in channel activity after exposure of glial cells to recombinant bovine basic fibroblast growth factor (bFGF, Amgen), 1.5 ~1 of 500 ng/ in1 bFGF was added to the bath (total volume, 1.5 ml). A stock solution (1000x) of nifedipine was dissolved in ethanol. Control experiments showed no effect on the calcium currents of 0.1% ethanol.
Data acquisition and analysis. Ion currents were recorded with the patch-clamp technique using the whole-cell recording configuration (Hamill et al., 198 1) . Fire-polished pipettes of borosilicate glass (World Precision Instruments; fiber filled) coated with Sylgard # 184 (Dow Coming) had resistances of 3-6 MB. A Dagan 3900 patch-clamp amplifier was used for whole-cell recording. The pipette potential was adjusted to 0 current flow before establishment of a seal. Pipette capacitance was minimized by capacity compensation circuitry on the patch-clamp amplifier. Series resistance was largely compensated by appropriate circuitry. Cell capacitance was estimated by using circuitry of the Dagan 39 10 expander module. Current signals were filtered at 1 kHz. Wholecell currents were evoked by command pulses and were sampled (250 psec/point) by a minicomputer (Vectra ES/ 12, Hewlett Packard) using ~CLAMP software (version 5.5, Axon Instruments) and an analog/digital converter (TL-1 DMA interface, Axon Instruments). Recordings are shown after subtraction of capacity and linear leak currents, determined by taking the average of 15 consecutive hyperpolarizing pulses 'As the size of the test potential. Whole-cell recordings from 89 cells were made as part of this study.
Cell proliferation assays. Retinal glial cells from a near confluent culture were removed from the dish by exposure for 15 min to 0.1% trypsin in CMF, centrifuged, and resuspended in 7 ml of 80% medium A and 20% fetal bovine serum. Aliquots (0.15 ml) of the cell suspension were placed on 8 x 8-mm grids that had been imprinted on the bottoms of 35-mm plastic Petri dishes. The grids, which were imprinted using a template (Mecanex SA), contained a 26 x 26 array of alphabetically labeled squares. The day following addition of the 0.15 mi suspension of cells, 1.5 ml of 80% medium A and 20% fetal bovine serum was added to each dish. On the second day after the initial plating, a baseline cell count was performed for each Petri dish by starting at one comer of the grid and proceeding systematically until at least 100 cells had been counted. Recording the label of the first and last squares of the grid counter permitted recounting of the same area later. After baseline counting, the Petri dishes were washed twice with Dulbecco's modified Eagle's medium and exposed to medium B, supplemented as needed with various concentrations of bFGF and nifedipine for 2 d. After this period, cells again were counted over the same areas of the grids as were surveyed for the baseline counts. Control experiments showed no effect of up to 0.5% ethanol, which was the vehicle for nifedipine, on bFGFinduced proliferation.
In experiments examining the incorporation of bromodeoxyuridine (BrdU) into DNA, cells on grid-stamped dishes were exposed for 2 d to 10 PM BrdU in medium B with or without 500 pg/ml bFGF. BrdU was localized by immunocytochemical methods similar to those used by Yong et al. (1988) , except the avidin-biotin-peroxidase method was used here. In brief, cultures were rinsed, then fixed with 70% ethanol at -20°C for 30 min, exposed to 2 h; HCl for 10 min to denature the DNA, bathed in 0.1 M sodium borate (pH, 9) for 10 min, and then exposed to a monoclonal antibodv to BrdIJ I1 : 10, Becton Dickinson) fo; 30 min at 37°C. Subsequently: the cultures were incubated in biotinylated anti-mouse IgG antibody (1: 1000; Vector) for 30 min at room temperature, followed by application of the avidin-biotin-peroxidase complex (1: 100; Vector) with development in diaminobenzidine.
Results
Mtogenic response of retinal glia to bFGF An initial question in this study was whether retinal glial cells are sensitive to bFGF. Because bFGF is a potent mitogen for a variety of cell types, and because glial proliferation occurs in retinal disorders in which bFGF may play a role, the mitogenic effect of this growth factor was assessed. Figure 1 shows the effect of various concentrations of bFGF on the proliferation of human retinal glial cells in culture. A concentration-dependent increase in the number of retinal glial cells was observed. The half-maximally effective concentration of bFGF was approximately 20 pg/ml. A maximal stimulatory effect occurred at concentrations greater than 100 pg/ml.
In addition to assaying cell number, the effect of bFGF on the incorporation of BrdU into the nuclei of the glial cells was determined. BrdU, an analog of the nucleotide thymidine, is incorporated into replicating DNA and can be detected by immunocytochemistry using an anti-BrdU monoclonal antibody. In triplicate experiments, cultures of human retinal glial cells were exposed for 2 d to medium B supplemented with 10 FM BrdU with or without bFGF (500 pg/ml). Exposure to bFGF was associated with a significantly (p = 0.018, Student's t test) higher percent of nuclei that were immunoreactive for BrdU. Specifically, immunocytochemistry revealed that 11% (SE = 3.5) of the glial cells in the control plates had nuclei positive for BrdU, while 41% (SE = 6.9) of the nuclei in the bFGFtreated group stained positively. These experiments demonstrated that the human retinal glial cells in our culture system are sensitive to bFGF.
Two types of voltage-gated calcium channels Because an influx of calcium may be one step in a cell's response to bFGF (Magnoldo et al., 1986; Pandrella et al., 1989) , we asked whether retinal glial cells have voltage-gated calcium channels that may be affected by this growth factor. Whole-cell recordings of membrane currents in retinal glial cells were performed with bath and pipette solutions that effectively isolated inward currents carried by barium (see Materials and Methods). Sodium channel current was eliminated by the blocking of sodium channels with 5 PM TTX and replacement of external sodium with cesium. Potassium channel current was abolished by having cesium in the bath and pipette solutions and having barium externally. Under these recording conditions, 7 1% (n = 83) of the retinal glial cells sampled had inward currents evoked by depolarization. Typically, there was little "run-down" of barium currents; approximately 90% of the maximal value for the peak inward current remained after 30 min of successful whole-cell recording. Of the cells with detectable current, the mean peak inward current after 10 min of recording was -223 pA (SE = 22; n = 59). The mean current density was 3.0 pAl pF (SE = 0.4). Two distinct types of inward currents could be elicited with strong depolarizing pulses: a transient response ( Fig. 2A) and a more long-lasting response (Fig. 2B) . Figure 3A shows leaksubtracted current records evoked by pulses from a holding potential of -100 mV in a cell that had chiefly a transient type of response. A plot of the voltage dependence of the peak inward current shows a threshold of activation at approximately -55 mV (Fig. 3B ). The inward current increased to a maximum amplitude at -10 mV and became smaller with progressively greater depolarizing pulses. The voltage dependence of the inactivation of this inward current was examined by varying the holding potential between -100 and -16 mV before applying a test pulse to 0 mV (Fig. 3C) . The peak amplitudes for the inactivation and activation of the current were normalized and plotted against membrane potential in Figure 30 . Inactivation was nearly complete at -40 mV, approximately half removed near -70 mV and fully removed near -100 mV. Activation of this transient current increased markedly over the range of potentials between -60 and -20 mV. Half-maximal activation occurred with pulses to approximately -38 mV. This transient inward current appears similar to the T-type of calcium current found in other types of cells (Fox et al., 1987; Bean, 1989) .
The characteristics of the long-lasting type of inward current are quite distinct from those for the T-type current. Figure 4A shows current records elicited by depolarizing pulses from a holding potential of -100 mV in a retinal glial cell with a longlasting type of inward current. A plot of the voltage dependence of the peak current shows a steep increase over the range of -25 I 50 ms OmV -lOOmVI Figure 2 . Two types of inward currents observed in human retinal glial cells under whole-cell recording conditions. Currents evoked with pulses from a holding potential of -100 to 0 mV. Current traces have been corrected for linear leak and capacitance currents. The bath solution consisted of 125 mM CsCl, 10 mM BaCl,, 10 mM glucose, 5 PM TTX, and 10 mM Ba-HEPES (pH, 7.3). The pipette solution contained 140 mM CsCl, 1 mM MgCl,, and 10 mM Cs-HEPES (pH, 7.3). A is from cell 1308-4; B is from cell 1297-3. to 0 mV (Fig. 4B ). This inward current was half-maximal with test potentials to approximately -13 mV (Fig. 4&D) . Figure  4C shows the current records when the holding potential was varied before pulsing to 0 mV. When normalized and plotted against membrane potential, this inward current was reduced by one-half at a holding potential of approximately -16 mV (Fig. 40) . Holding potentials more negative than -30 mV had only modest effects (Fig. 40) . The small degree of activation and inactivation seen in Figure 40 at membrane potentials more negative than -25 mV is likely to be due to the presence of a small T-type current in this cell. The high-threshold, long-lasting response of this cell is similar to the L-type of calcium current observed in a variety of cell types (Fox et al., 1987; Bean, 1989) .
Of the sampled retinal glial cells with voltage-sensitive calcium channels, more than 90% had both T-and L-currents, based on thresholds for activation. An example of a glial cell with a current-voltage relationship indicating the presence of two types of inward currents is shown in Figure 5 . An inward current was initially activated at a threshold of about -5 5 mV, but increased much more steeply at potentials positive to -15 mV. As was the case for the cell studied in Figure 5 , a majority of the sampled cells had L-type currents that were larger than the T-type.
In addition to differences in the voltage dependence of activation and inactivation, T-and L-type currents in the retinal glial cells could be distinguished pharmacologically. The dihydropyridine nifedipine could reduce the L-type current. In Figure 6 , voltage protocols were chosen to help isolate the T-type ( Fig. 64 and the L-type currents (Fig. 6B ) in a glial cell. When a bath solution containing 1 PM nifedipine was miniperfused in the area of this cell, the L-type current was reduced by approximately 50%, while the T-type current was minimally affected. Reductions in the L-type current of greater than 50% were not observed even with 10 I.LM nifedipine (five cells tested). There was some variability in the effect of nifedipine on L-type currents. Although four of five tested glial cells had approximately a 50% reduction in L-type current with perfusion of 10 PM nifedipine, one cell had no detectable effect of the dihydropyr-
idine. In three cells exposed to a perfusate containing 1 PM nifedipine, the reduction in L-type current ranged from approximately 25% to 50%. Significant reductions in T-type currents were not detected in eight cells exposed to 1 or 10 PM nifedipine. Although studies of other cell types indicate that L-type channels have a high affinity receptor for dihydropyridines when the channel is inactivated (Bean, 1989) , we observed up to a 50% inhibitory effect by nifedipine when the L-type channel was in the resting state ( Figure 6B ). Voltage dependency of the nifedipine block was not systematically examined here. 
Increased inward current after bFGF exposure
The possibility that exposure to bFGF may be associated with a change in the activity of voltage-gated calcium channels was examined. Whole-cell recordings under conditions to isolate currents carried by barium were monitored continuously before and after exposure to bFGF. Figure 7 shows an example of an increase in inward current 14 min after the onset of miniperfusion in the area of this glial cell with a bath solution containing 500 pg/ml bFGF. Each trace in Figure 7A is averaged from four runs. The peak current increased by 24%. This difference between the peak currents in the control period and after bFGF exposure was significant (p <c 0.001, Student's t test). In Figure   7B , the current-voltage plots for this cell before and 15-20 min after exposure to bFGF are shown. The inward current with the higher threshold of activation increased after bFGF exposure, while the inward current elicited at the lower threshold changed little.
In glial cells having predominantly an L-type current, an increase in peak inward current was detected in seven of seven sampled cells. The mean increase elicited with depolarizations from a holding potential of -100 mV was 40% (range, 14-l 00%; SE = 11; n = 7) after lo-20 min of exposure to bFGF. In contrast, in 10 cells with predominantly a T-type current, no increase of greater than 10% was detected under similar recording conditions, suggesting that exposure to bFGF was associated with a selective increase in L-type currents.
Because guanine nucleotide-binding proteins (G-proteins) are likely to be involved in the regulation of voltage-gated calcium channels in some cell types (Schultz et al., 1990) , we examined whether pertussis toxin, an inactivator of G-proteins in many cell types (Graviano and Gilman, 1987) affected the increase in L-type current associated with the exposure of retinal glial cells to bFGF. Cultures were exposed to medium B supplemented with 100 rig/ml pertussis toxin for 15-22 hr prior to whole-cell recording. During the electrophysiological recordings, pertussis toxin (100 &ml) was in the bath solution. Five cells with L-type currents of at least 100 pA were studied. An increase in peak current of 32% (SE = 10) was detected within 20 min of the addition of bFGF (final concentration, 500 pg/ ml) to the bath solution. This increase was not statistically different (p = 0.5, Student's t test) from the augmentation found in the absence of pertussis toxin.
Nifdipine inhibits bFGF-induced proliferation
Finding that bFGF exposure was associated with an increase in L-type calcium current led to the question ofwhether nifedipine, a blocker of the L-type channels (Fig. 6B) , could inhibit the proliferative effect of bFGF. As shown in Figure 8 , nifedipine does inhibit the bFGF-induced proliferation of retinal glial cells in a dose-dependent manner. The half-maximally effective concentration of nifedipine is approximately 0.5 PM. Inhibition of proliferation by nifedipine did not appear to be a toxic effect because cell viability was unaffected by a 2-d exposure to 10 PM nifedipine as assayed by trypan blue dye exclusion. Also, glial cell number was not reduced in cultures maintained in medium B supplemented with 10 PM nifedipine for 2 d. Further evidence for a lack of toxicity was that removal of the nifedipine-containing medium after 2 d and the subsequent addition of bFGF (500 pg/ml) for 36 hr led to a 35% (SE = 5; n = 2) increase in the number of retinal glial cells. These experiments indicate that the proliferative response of retinal glial cells to bFGF involves a dihydropyridine-sensitive mechanism.
Discussion bFGF is a good candidate as a molecule that may play a role in retinal pathobiology. Importantly, bFGF is present in the mammalian retina (Gospodarowicz et al., 1986) . Also, it can be detected in the vitreous of patients with various retinal disorders (Sivalingam et al., 1990) . The recent finding that glia from bovine retina have binding sites for bFGF (Mascarelli et al., 1990) suggests that these cells may be targets for this growth factor. In agreement with this possibility is our observation that bFGF is mitogenic for retinal glial cells. This proliferative effect of bFGF on glial cells of the retina is consistent with previous studies demonstrating a mitogenic response of cerebral glia to this growth factor (Gospodarowicz et al., 1985; Kniss and Burry, 1988) . Our experiments indicate that exposure to bFGF is associated with an enhancement of the L-type calcium current in retinal glial cells. Previous studies have suggested that an influx of calcium may be one of the cellular responses to bFGF. Future studies are needed to elucidate the mechanism by which exposure to bFGF is associated with an increase in L-type calcium currents. Possible ways for augmenting these currents include an alteration in gating kinetics, an unmasking of covert calcium channels, and changes in channel availability (Tsien et al., 1988) . Although G-proteins are implicated in the regulation of L-type currents in a variety of cell types (Tsien et al., 1988; Schultz et al., 1990) our finding that pertussis toxin, an inactivator of G-proteins in many systems (Graviano and Gilman, 1987) did not block a bFGF-induced increase in barium current does not support a role for G-proteins in the modulation of calcium channels by bFGF in retinal glial cells. Our lack of evidence for involvement of G-proteins is consistent with other studies failing to find G-proteins as mediators of the effects of bFGF (Chambard et al., 1987) . Also, G-protein-independent mechanisms for enhancing L-type calcium currents have been implicated for other non-neural cells (Callewaert et al., 1989; Smith et al., 1989 ). However, it should be noted that pertussis toxin has not been demonstrated to block G-proteins in retinal glial cells. For the future, the use of the patch-clamp technique to analyze single-channel activity will be helpful in evaluating mechanisms by which bFGF may modulate voltage-gated calcium channels in retinal glial cells.
glial cells express two types of voltage-gated calcium currents (T-and L-types). The dihydropyridine nifedipine distinguishes between the two types of inward currents by blocking preferentially the L-type current.
The role of voltage-gated calcium channels in the physiology of glial cells is unclear. It seems possible that potassium released by neurons into the extracellular space could depolarize the glial cell enough to activate low-threshold, T-type calcium channels. An influx of calcium via these channels with subsequent activation of calcium-activated potassium channels perhaps could aid in the regulation of extracellular potassium levels (Newman, 1985) . Although T-type currents may be activated under physiological conditions, it is less likely that glial cells would be depolarized profoundly enough to activate L-type calcium channels under normal conditions. However, a marked reduction in the membrane potential of glial cells may occur under pathophysiological conditions, such as anoxia or cell injury. If depolarized retinal glial cells were also exposed to bFGF, our experiments suggest that calcium influx through L-type channels would be augmented. Because calcium is involved in many important cellular events, this enhanced influx could perhaps affect significantly the response of the retina to pathophysiological conditions causing severe depolarization. This is the first report of voltage-gated calcium channels in
Whether there is a link between the modulation of L-type glial cells from the adult mammalian CNS, though glia from calcium currents and the proliferative response to bFGF is unthe perinatal nervous system are known to express these types certain. The temporal correlation of exposure to bFGF and of channels (MacVicar, 1984; Barres et al., 1988 Barres et al., ,1989 ; MacVicar augmentation of L-type current is consistent with a possible role and Tse, 1988; Corvalan et al., 1990) , and a high-threshold of these calcium channels in mediating the proliferative response calcium current has been found in glia of the salamander retina of retinal glia to this growth factor. The finding that nifedipine (Newman, 1985) . In this study we found that the human retinal inhibits both the L-type current and the bFGF-induced prolif- eration of glia further suggests that dihydropyridine-sensitive channels may play a role in this mitogenic response. However, definitive proof of a link between calcium currents and proliferation remains to be established. For example, at present it is not known precisely how raised intracellular calcium levels would lead to or provide an environment conducive for DNA synthesis. Also, a concern regarding our experiments is the possibility that nifedipine affects other cellular events in addition to calcium channels. We cannot exclude this possibility, though the half-maximal concentration for the block of glial proliferation by nifedipine is approximately 0.5 PM, a relatively low dose of this dihydropyridine. Also, an important unresolved issue is whether retinal glial cells become depolarized sufficiently after bFGF exposure for the high-threshold calcium channels to become activated. Our monitoring of the membrane potentials of retinal glial cells indicates that bFGF does not induce a rapid (< 15 min) reduction in membrane potential to the level necessary to activate L-type currents (D. G. Pure, unpublished observations). Despite this, it is possible that, over longer periods during the cell cycle, significant transient changes in the membrane potential may occur. Activation of sodium channels and/or divalent permeable nonspecific calcium channels, which are expressed by the human retinal glial cells (Puro, 199 l) , is a possible mechanism for eliciting transient depolarizations. Perhaps intermittent depolarizations during the cell cycle activate influxes of calcium via L-type channels. Further experiments are required to evaluate these possibilities.
The culture system used here appears to be a reasonable system in which to study aspects of the pathophysiology of human retinal glial cells. The cells in culture are immunoreactive to antibodies specific for GFAP and Miiller's cells Puro et al., 1990) as are cells often found in multicellular complexes (so-called epiretinal and preretinal "membranes") located on the retinal surface or extending into the vitreous in eyes with various retinal diseases (Rodrigues et al., 198 1; Hiscott et al., 1984; Chan et al., 1986 Chan et al., , 1988 Jerdan et al., 1989; Sramek et al., 1989; Vinores et al., 1990) . However, despite these similarities, it remains to be demonstrated that the ion channels found in the cultured cells are, in fact, also expressed by retinal glial cells in vivo. Although in vivo electrophysiological studies of calcium channels in retinal cells are lacking, the finding of voltage-gated calcium current in Mtiller's glia in a slice preparation of the salamander retina (Newman, 1985) strongly suggests that certain calcium channels are present in these cells in vivo at least in some vertebrates. Clearly, an in vitro system is essential in order to use the patch-clamp technique to study cells of the human retina. An advantage of a cell culture system is the ability to assay the effects on human retinal glial cells of defined concentrations of specific growth factors under serumfree conditions in the absence of significant numbers of nonglial cells.
Although bFGF influences retinal glial cells in vitro, this remains to be demonstrated in vivo. An important issue conceming bFGF actions in vivo is how this molecule is secreted from cells, because it lacks a signal sequence (Abraham et al., 1986; R&in and Moscatelli, 1989) . In addition, effects of bFGF may be limited by the strong affinity of this growth factor for the extracellular matrix (Folkman et al., 1988; Rilkin and Moscatelli, 1989) . Whether unbound, extracellular bFGF is available under normal physiological conditions in the retina or brain is unknown. It has been postulated that bFGF may be released during ischemia and/or cell damage (Gajdusek and Carbon, 1989; Ritkin and Moscatelli, 1989) . Quantification of changes in bFGF levels in the retina with disease or injury is lacking. However, in the brain, increased levels of bFGF-like immunoreactivity are found adjacent to wound sites (Finkelstein et al., 1988) .
Our experiments suggest that exposure to bFGF may stimulate the proliferation of retinal glial cells by a dihydropyridinesensitive mechanism. A proliferation of glia may be an adaptive response of the nervous system resulting in the creation of more glial cells that would help regulate potassium levels and remove potentially toxic molecules, such as glutamate. On the other hand, the proliferation of glial cells often is a significant factor in compromising neural function with disease or injury. For example, in the retina, proliferating glia can become part of multicellular complexes that may reduce neuronal function by causing detachment of the retina from the underlying retinal pigment epithelium (Laqua and Machemer, 1975) . Whether drugs such as nifedipine may be useful in modifying the detrimental responsesofglial cells to pathological conditions remains to be determined.
